Form 4: Rapid Micro Biosystems CEO Exercises Stock Options

Rapid Micro Biosystems CEO Robert G. Spignesi Jr. exercised stock options, resulting in a net acquisition of 4,387 Class A Common Stock shares.

Summary

• Robert G. Spignesi Jr., President and CEO of Rapid Micro Biosystems, Inc. (RPID), exercised stock options on October 17, 2025.
• A total of 11,233 Class A Common Stock options were exercised at a price of $0.75 per share.
• The company withheld 6,846 shares of Class A Common Stock to cover the exercise price and tax withholdings.
• The withholding was based on the closing stock price of $3.08 per share on October 17, 2025.
• Following the net exercise, Mr. Spignesi Jr. received a net total of 4,387 shares of Class A Common Stock.
• His direct beneficial ownership of Class A Common Stock increased to 974,937 shares after these transactions.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the transaction is routine, the net acquisition of shares by the CEO indicates continued alignment of interests with shareholders and confidence in the company, despite a portion being withheld for taxes.

Positives

• The CEO's exercise of stock options and subsequent net acquisition of shares can be viewed as a positive signal of confidence in the company's future prospects.
• The options were fully vested and exercisable, indicating a planned transaction as part of executive compensation.

Negatives

• A significant portion of the exercised shares (6,846 shares) were withheld by the company for tax obligations and exercise price, rather than being fully retained by the CEO.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The net acquisition of shares by the CEO may be perceived positively, signaling management's belief in the company's value and aligning executive interests with shareholder returns.

Key Dates

Recommendation

This Form 4 reports a routine exercise of vested stock options by the CEO, which is a common compensation event. While it results in a net acquisition of shares, it does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transaction is largely neutral in its implications for the stock's intrinsic value.

Keywords

RPID, Rapid Micro Biosystems, Insider Transaction, Stock Options, CEO, Beneficial Ownership, Form 4